About
0.23CAD+0.00 +0.00%
Closed • Updated at 21:18 GMT+00:00Market Cap$42.89M
Volume52.7K
Beta-0.09
RSI41.43
Gross Margin31.75%
Theralase Technologies Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 20 2026
Theralase(R) Closes C$4.8 Million Offering
May 5 2026
Theralase(R) Announces $4 Million Brokered LIFE Offering
May 4 2026
Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
Apr 13 2026
Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
Apr 10 2026
Theralase(R) Closes $CAN 2.66 Million Financing
Community Chat
Ask AI
Try asking
Translate